- Title
- P1155: BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ROUTINE PRACTICE: UPDATED REPORT FROM THE US LYMPHOMA CAR T CONSORTIUM
- Creators
- Y. Wang - Mayo Clinic, RochesterP. Jain - The University of Texas MD Anderson Cancer CenterF. Locke - Moffitt Cancer CenterM. Maurer - Winneshiek Medical CenterM. Frank - Stanford MedicineJ. Munoz - Mayo Clinic, PhoenixS. Dahiya - University of Maryland School of Medicine, Greenebaum Comprehensive Cancer Center, BaltimoreA. Beitinjaneh - University of MiamiM. Jacobs - Washington University School of Medicine, Siteman Cancer Center, St LouisJ. Mcguirk - University of Kansas Medical CenterJ. Vose - University of Nebraska Medical CenterA. Goy - Hackensack Meridian HealthC. Andreadis - University of California, San FranciscoB. Hill - Cleveland ClinicK. Dorritie - UPMC Hillman Cancer CenterO. Oluwole - Vanderbilt-Ingram Cancer Center, NashvilleA. Deol - Wayne State UniversityB. Shah - Moffitt Cancer CenterJ. Paludo - Mayo Clinic, RochesterT. Wang - University of MiamiR. Banerjee - University of California, San FranciscoS. Neelapu - The University of Texas MD Anderson Cancer CenterD. Miklos - Stanford MedicineA. Rapoport - University of Maryland School of Medicine, Greenebaum Comprehensive Cancer Center, BaltimoreL. Lekakis - University of MiamiA. Ghobadi - Washington University School of Medicine, Siteman Cancer Center, St LouisY. Lin - Mayo Clinic, RochesterM. Wang - The University of Texas MD Anderson Cancer CenterM. Jain - Moffitt Cancer Center
- Publication Details
- HemaSphere, Vol.6(Suppl), pp.1042-1043
- Publisher
- Lippincott Williams & Wilkins
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031757846902976
Journal article
P1155: BREXUCABTAGENE AUTOLEUCEL FOR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ROUTINE PRACTICE: UPDATED REPORT FROM THE US LYMPHOMA CAR T CONSORTIUM
HemaSphere, Vol.6(Suppl), pp.1042-1043
2022-06-23
Metrics
13 Record Views